Posted in | News | Nanofabrication

Veeco’s EPIK700 MOCVD System Accepted by Epistar for High Volume LED Production

Veeco Instruments Inc. announced today that Epistar Corporation has successfully evaluated and accepted the new TurboDisc® EPIK700™ Gallium Nitride (GaN) Metal Organic Chemical Vapor Deposition (MOCVD) system for the production of light emitting diodes (LEDs).

“As the leader in LED technology and commercialization, it is vital that we continue to push our roadmap to reduce solid state lighting costs with the most innovative and efficient production solutions available,” said Dr. MJ Jou, President, Epistar Corporation. “EPIK’s performance, reliability and production readiness, as well as the support we received from Veeco during the beta testing phase, fully met our high manufacturing standards. The seamless recipe transfer from our installed base of Veeco K465i™ and MaxBright® systems to the EPIK700 is allowing us to quickly produce production-quality LED devices. In addition, the EPIK700’s cost of ownership advantage will help reduce our cost per wafer, making it a highly attractive platform for our future capacity expansions.”

Based on Veeco’s proven TurboDisc technology, the newly launched EPIK700 MOCVD system enables customers to achieve a cost per wafer savings of up to 20 percent compared to previous MOCVD systems through improved wafer uniformity, reduced operating expenses and increased productivity.

“Given Epistar’s position as one of the world’s top LED manufacturers, we are excited to have achieved this significant milestone and look forward to supporting future Epistar expansions in Taiwan and China,” said Jim Jenson, Senior Vice President, Veeco MOCVD Operations. “Our goal at Veeco is to help customers further accelerate the solid-state lighting market by driving down LED manufacturing costs and increasing productivity. We are gratified by this strong endorsement of EPIK700’s production-readiness.”

Source: http://www.veeco.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.